Comparison of Erythema Migrans Caused by Borrelia afzelii and Borrelia garinii

Infection

Volumn 32, Issue 1, 2004, Pages 15-19

  Logar, M ^a   Ruzic Sabljic E ^b   Maraspin, V ^a   Lotric Furlan S ^a   Cimperman, J ^a   Jurca, J ^a   Strle, F ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BACTERIUM ISOLATION; BODY DISTRIBUTION; BORRELIA AFZELII; BORRELIA GARINII; BORRELIA INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; EPIDEMIOLOGICAL DATA; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMAN; HUMAN TISSUE; INCUBATION TIME; LIMB; LIVER FUNCTION TEST; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; SEROLOGY; SKIN DEFECT; SKIN INFECTION; SPECIES DIFFERENCE; SYMPTOM; SYSTEMIC DISEASE; TRUNK;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BORRELIA BURGDORFERI GROUP; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 1142273174     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-004-3042-z     Document Type: Article

References (22)

1. Steere AC: Lyme disease. N Engl J Med 2001; 345: 115-125.
2. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, Maraspin V, Aguero-Rosenfeld ME, Varde S, Lotrič-Furlan S, Wormser GP: Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999; 130: 32-36.
3. Picken RN, Cheng Y, Strle F, Cimperman J, Maraspin V, Lotrič-Furlan S, Ružić-Sabljić E, Han D, Nelson JA, Picken MM, Trenholme GM: Molecular characterization of Borrelia burgdorferi sensu lato from Slovenia revealing significant differences between tick and human isolates. Eur J Clin Microbiol Infect Dis 1996; 15: 313-323.
4. Picken RN, Strle F, Ružić-Sabljić E, Maraspin V, Lotrič-Furlan S, Cimperman J, Cheng Y, Picken MM: Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphocytoma. J Invest Dermatol 1997; 108: 92-97.
5. Ružić-Sabljić E, Maraspin V, Lotrič-Furlan S, Jurca T, Logar M, Pikelj-Pečnik A, Strle F: Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr 2002; 114: 544-550.
6. Van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, Ramselaar AC, Kramer MD, Dankert J: Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.Clin Infect Dis 1993; 17: 708-717.
7. Balmelli T, Piffaretti JC: Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995; 146: 329-340.
8. Anthonissen FM, De Kesel M, Hoet PP, Bigaignon GH: Evidence for the involvement of different genospecies of Borrelia in the clinical outcome of Lyme disease in Belgium. Res Microbiol 1994; 145: 327-331.
9. Centers for Disease Control: Lyme disease surveillance - United States. 1989-1990. MMMR 1991; 40: 417-421.
10. Wilske B, Schierz G, Preac-Mursic V, Weber K, Pfister HW, Einhaupl K: Serological diagnosis of erythema migrans disease and related disorders. Infection 1984; 12: 331-337.
11. Strle F, Nelson JA, Ružić-Sabljić E, Cimperman J, Maraspin V, Lotrič-Furlan S, Cheng Y, Picken MM, Trenholme GM, Picken RN: European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis 1996; 23: 61-65.
12. Strle F, Preac-Mursic V, Cimperman J, Ružić E, Maraspin V, Jereb M: Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 1993; 21: 83-88.
13. Preac-Mursic V, Wilske B, Schierz G: European Borrelia burgdorferi isolated from humans and ticks - culture conditions and antibiotic susceptibility. Zbl Bakt Hyg A 1986; 263: 112-118.
14. Ružić-Sabljić E, Strle F, Cimperman J, Maraspin V, Lotrič-Furlan S, Pleterski-Rigler D: Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J Med Microbiol 2000; 49: 47-53.
15. Belfaiza J, Postic D, Bellenger E, Baranton G, Saint Girons I: Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis. J Clin Microbiol 1993; 31: 2873-2877.
16. Asbrink E, Olsson I, Hovmark A: Erythema chronicum migrans Afzelius in Sweden. A study on 231 patients. Zbl Bakt Hyg A 1986; 263: 229-236.
17. Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP:The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996; 100: 502-508.
18. Logar M, Lotrič-Furlan S, Maraspin V, Cimperman J, Jurca T, Ružić-Sabljić E, Strle F: Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans? Wien Klin Wochenschr 1999; 111: 945-950.
19. Strle F, Videčnik J, Zorman P, Cimperman J, Lotrić-Furlan S, Maraspin V: Clinical and epidemiological findings for patients with erythema migrans. Comparison of cohorts from the years 1993 and 2000. Wien Klin Wochenschr 2002; 114: 493-497.
20. Weber K, Neubert U: Clinical features of early erythema migrans disease and related disorders. Zbl Bakt Hyg A 1986; 263: 209-228.
21. Strle F, Maraspin V, Furlan-Lotrič S, Cimperman J: Epidemiological study of a cohort of adult patients with erythema migrans registered in Slovenia in 1993. Eur J Epidemiol 1996; 12: 503-507.
22. Strle F, Maraspin V, Lotrič-Furlan S, Ružić- Sabljić E, Cimperman J: Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection 1996; 24: 64-68.